Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Adenocarcinoma Resectable”

253 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 253 results

Testing effectiveness (Phase 2)WithdrawnNCT00882765
What this trial is testing

Genistein in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

Who this might be right for
Pancreatic Cancer
Jonsson Comprehensive Cancer Center
Not applicableLooking for participantsNCT06320717
What this trial is testing

AI Derived Biomarker to Select Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Roswell Park Cancer Institute 100
Not applicableLooking for participantsNCT06595160
What this trial is testing

Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy

Who this might be right for
Borderline Resectable Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal AdenocarcinomaStage I Pancreatic Cancer AJCC v8
Emory University 87
Early research (Phase 1)Active Not RecruitingNCT02495896
What this trial is testing

Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMetastatic Pancreatic AdenocarcinomaNon-Resectable Cholangiocarcinoma+13 more
University of Southern California 61
Testing effectiveness (Phase 2)Looking for participantsNCT04926467
What this trial is testing

Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic Adenocarcinoma
Baylor Research Institute 24
Very early researchStudy completedNCT01992705
What this trial is testing

Borderline Pancreas Study: FOLFIRINOX +SBRT

Who this might be right for
Resectable Pancreatic Cancer
University of Maryland, Baltimore 8
Not applicableUnknownNCT05489458
What this trial is testing

Predictive Factors for Resection and Survival in Type A Borderline Resectable Pancreatic Ductal Adenocarcinoma Patients After Neoadjuvant Therapy

Who this might be right for
Carcinoma, Pancreatic Ductal
BUSQUETS, JULI 100
Testing effectiveness (Phase 2)Ended earlyNCT01760252
What this trial is testing

Neoadjuvant CAPOXIRI Chemotherapy in the Treatment of Pancreatic Adenocarcinoma Protocol

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Beth Israel Medical Center 17
Testing effectiveness (Phase 2)WithdrawnNCT03908333
What this trial is testing

High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic CancerPancreatic CancerPancreas Cancer+3 more
Medical College of Wisconsin
Testing effectiveness (Phase 2)Study completedNCT01560949
What this trial is testing

Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 34
Not applicableUnknownNCT06214533
What this trial is testing

Celiac plExus Block to Reduce OpioID Consumption Following Hepato-pancreato-biliary Mini-invasive Surgery

Who this might be right for
Pancreatic Ductal AdenocarcinomaLiver, Cancer of, Primary Resectable
Sixth Affiliated Hospital, Sun Yat-sen University 60
Testing effectiveness (Phase 2)Study completedNCT02749136
What this trial is testing

Neoadjuvant Modified FOLFIRINOX in Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Asan Medical Center 44
Testing effectiveness (Phase 2)WithdrawnNCT04130399
What this trial is testing

Study of Neoadjuvent Chemotherapy Followed by SBRT in Patients With Resectable and Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic Adenocarcinoma
Indiana University
Not applicableStudy completedNCT05888129
What this trial is testing

Clinical Outcomes of Surgery After Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer

Who this might be right for
Postoperative Complications
Asan Medical Center 1
Large-scale testing (Phase 3)Active Not RecruitingNCT04340141
What this trial is testing

Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer

Who this might be right for
Pancreatic Adenosquamous CarcinomaResectable Pancreatic AdenocarcinomaPancreatic Cancer
Alliance for Clinical Trials in Oncology 358
Early research (Phase 1)Study completedNCT02030860
What this trial is testing

Neoadjuvant Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the Pancreas
Abramson Cancer Center at Penn Medicine 15
Early research (Phase 1)UnknownNCT02599662
What this trial is testing

Intraoperative Radiation Therapy for Resectable Pancreas Cancer

Who this might be right for
Pancreas Cancer
Loyola University 12
Early research (Phase 1)Study completedNCT03373188
What this trial is testing

VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer

Who this might be right for
Colon Carcinoma Metastatic in the LiverColorectal AdenocarcinomaPancreatic Adenocarcinoma+11 more
Emory University 10
Testing effectiveness (Phase 2)Study completedNCT00609336
What this trial is testing

Perioperative Therapy for Resectable Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasStage IA Pancreatic CancerStage IB Pancreatic Cancer+2 more
University of Washington 35
Testing effectiveness (Phase 2)Looking for participantsNCT06821997
What this trial is testing

NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar Trial

Who this might be right for
Borderline Resectable Pancreatic Ductal Adenocarcinoma
Roswell Park Cancer Institute 20
Load More Results